Alivus Life Sciences Limited has informed the Exchange about Schedule of meet
ALIVUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alivus Life Sciences has informed the stock exchanges about an upcoming investor/analyst meeting scheduled for August 7, 2025. The meeting will be held in-person in Mumbai with Julius Baer in a one-on-one format. The filing has been made under SEBI Listing Regulations as a standard disclosure of meeting schedules. The company noted that the schedule and mode may change due to unforeseen circumstances.
This is a routine disclosure with no material business or financial information shared. It does not directly affect the stock price, but signals ongoing investor engagement by the company.